World Library  
Flag as Inappropriate
Email this Article

Deltorphin I

Article Id: WHEBN0035582176
Reproduction Date:

Title: Deltorphin I  
Author: World Heritage Encyclopedia
Language: English
Subject: Deltorphin, List of opioids, Phyllomedusa bicolor, Peptides, Kobret
Collection: Amides, Analgesics, Opioids, Peptides
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Deltorphin I

Deltorphin I
Identifiers
CAS number
PubChem
ChemSpider
ChEMBL
Jmol-3D images Image 1
Properties
Molecular formula C37H52N8O10
Molar mass 768.856 g/mol
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)

Deltorphin I, also known as [D-Ala2]deltorphin I or deltorphin C, is a naturally-occurring, exogenous opioid heptapeptide and hence, exorphin, with the amino acid sequence Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2.[1][2] While not known to be endogenous to humans or other mammals, deltorphin I, along with the other deltorphins and the dermorphins, is produced naturally in the skin of species of Phyllomedusa,[1] a genus of frogs native to South and Central America. Deltorphin possesses very high affinity and selectivity as an agonist for the δ-opioid receptor,[1][2] and on account of its unusually high blood-brain-barrier penetration rate,[3] produces centrally-mediated analgesic effects in animals even when administered peripherally.[4]

See also

References

  1. ^ a b c Erspamer V, Melchiorri P, Falconieri-Erspamer G, et al. (July 1989). "Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites". Proceedings of the National Academy of Sciences of the United States of America 86 (13): 5188–92.  
  2. ^ a b Balboni G, Marastoni M, Picone D, et al. (June 1990). "New features of the delta opioid receptor: conformational properties of deltorphin I analogues". Biochemical and Biophysical Research Communications 169 (2): 617–22.  
  3. ^ Fiori A, Cardelli P, Negri L, Savi MR, Strom R, Erspamer V (August 1997). "Deltorphin transport across the blood–brain barrier". Proceedings of the National Academy of Sciences of the United States of America 94 (17): 9469–74.  
  4. ^ Thomas SA, Abbruscato TJ, Hau VS, et al. (May 1997). "Structure-activity relationships of a series of [D-Ala2]deltorphin I and II analogues; in vitro blood–brain barrier permeability and stability". The Journal of Pharmacology and Experimental Therapeutics 281 (2): 817–25.  


This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 



Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.